Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 234

Similar articles for PubMed (Select 21203389)

1.

Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial.

Tagbor H, Bruce J, Agbo M, Greenwood B, Chandramohan D.

PLoS One. 2010 Dec 28;5(12):e14425. doi: 10.1371/journal.pone.0014425.

2.

Factors influencing the usage of different types of malaria prevention methods during pregnancy in Kenya.

Choonara S, Odimegwu CO, Elwange BC.

Afr Health Sci. 2015 Jun;15(2):413-9. doi: 10.4314/ahs.v15i2.14.

3.

The prevalence of P. falciparum resistance markers to sulphadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment of malaria in Uganda.

Mbonye AK, Birungi J, Yanow SK, Shokoples S, Malamba S, Alifrangis M, Magnussen P.

Antimicrob Agents Chemother. 2015 Jun 29. pii: AAC.00507-15. [Epub ahead of print]

PMID:
26124154
4.

Evolution of malaria in pregnancy control: Jhpiego's 10-year contribution.

Roman E, Ngindu A, Orji B, Zoungrana J, Robbins S, Brieger W.

Int J Gynaecol Obstet. 2015 Jun;130 Suppl 2:S62-7. doi: 10.1016/j.ijgo.2015.03.009.

PMID:
26115860
5.
6.

Intermittent presumptive treatment in pregnancy with sulfadoxine-pyrimethamine: a counter perspective.

Nosten F, McGready R.

Malar J. 2015 Jun 20;14(1):248. doi: 10.1186/s12936-015-0765-5.

7.

Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability.

Briand V, Escolano S, Journot V, Massougbodji A, Cot M, Tubert-Bitter P.

Am J Trop Med Hyg. 2015 Jun 8. pii: 14-0783. [Epub ahead of print]

PMID:
26055735
8.

Predictors for uptake of intermittent preventive treatment of malaria in pregnancy (IPTp) in Tanzania.

Kibusi SM, Kimunai E, Hines CS.

BMC Public Health. 2015 Jun 7;15:540. doi: 10.1186/s12889-015-1905-0.

9.

Determinants of infant susceptibility to malaria during the first year of life in South Western cameroon.

Apinjoh TO, Anchang-Kimbi JK, Mugri RN, Njua-Yafi C, Tata RB, Chi HF, Tangoh DA, Loh BT, Achidi EA.

Open Forum Infect Dis. 2015 Feb 28;2(1):ofv012. doi: 10.1093/ofid/ofv012. eCollection 2015 Jan.

10.

Analysis of Preventive Interventions for Malaria: Exploring Partial and Complete Protection and Total and Primary Intervention Effects.

Cairns M, Cheung YB, Xu Y, Asante KP, Owusu-Agyei S, Diallo D, Konate AT, Dicko A, Chandramohan D, Greenwood B, Milligan P.

Am J Epidemiol. 2015 Jun 15;181(12):1008-17. doi: 10.1093/aje/kwv010. Epub 2015 May 27.

11.

Malaria preventive therapy in pregnancy and its potential impact on immunity to malaria in an area of declining transmission.

Teo A, Hasang W, Randall LM, Unger HW, Siba PM, Mueller I, Brown GV, Rogerson SJ.

Malar J. 2015 May 26;14:215. doi: 10.1186/s12936-015-0736-x.

12.

Global Call to Action to scale-up coverage of intermittent preventive treatment of malaria in pregnancy: seminar report.

Agarwal K, Alonso P, Chico RM, Coleman J, Dellicour S, Hill J, Majeres-Lugand M, Mangiaterra V, Menendez C, Mitchell K, Roman E, Sicuri E, Tagbor H, van Eijk AM, Webster J.

Malar J. 2015 May 18;14:206. doi: 10.1186/s12936-015-0730-3.

13.

Global Call to Action: maximize the public health impact of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa.

Chico RM, Dellicour S, Roman E, Mangiaterra V, Coleman J, Menendez C, Majeres-Lugand M, Webster J, Hill J.

Malar J. 2015 May 18;14:207. doi: 10.1186/s12936-015-0728-x.

14.

Estimating the uptake of maternal syphilis screening and other antenatal interventions before and after national rollout of syphilis point-of-care testing in Ghana.

Dassah ET, Adu-Sarkodie Y, Mayaud P.

Int J Gynaecol Obstet. 2015 Jun;130 Suppl 1:S63-9. doi: 10.1016/j.ijgo.2015.04.013. Epub 2015 Apr 29.

15.

In vivo efficacy of sulphadoxine-pyrimethamine for the treatment of asymptomatic parasitaemia in pregnant women in Machinga District, Malawi.

Gutman J, Mwandama D, Wiegand RE, Abdallah J, Iriemenam NC, Shi YP, Mathanga DP, Skarbinski J.

Malar J. 2015 May 13;14:197. doi: 10.1186/s12936-015-0710-7.

16.
17.

Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy.

Sicuri E, Fernandes S, Macete E, González R, Mombo-Ngoma G, Massougbodgi A, Abdulla S, Kuwawenaruwa A, Katana A, Desai M, Cot M, Ramharter M, Kremsner P, Slustker L, Aponte J, Hanson K, Menéndez C.

PLoS One. 2015 Apr 27;10(4):e0125072. doi: 10.1371/journal.pone.0125072. eCollection 2015.

18.

Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.

Mace KE, Chalwe V, Katalenich BL, Nambozi M, Mubikayi L, Mulele CK, Wiegand RE, Filler SJ, Kamuliwo M, Craig AS, Tan KR.

Malar J. 2015 Feb 7;14:69. doi: 10.1186/s12936-015-0576-8.

19.

Factors associated with failure to screen for syphilis during antenatal care in Ghana: a case control study.

Dassah ET, Adu-Sarkodie Y, Mayaud P.

BMC Infect Dis. 2015 Mar 13;15:125. doi: 10.1186/s12879-015-0868-1.

20.

Exposure to artemether-lumefantrine (Coartem) in first trimester pregnancy in an observational study in Zambia.

Manyando C, Njunju EM, Virtanen M, Hamed K, Gomes M, Van Geertruyden JP.

Malar J. 2015 Feb 14;14:77. doi: 10.1186/s12936-015-0578-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk